Sasha Shumpert
Nurse Practitioner · Columbia City, INNPI 1467959692
Payments from drug & device makers
Across 323 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$856
- Lilly USA, LLC$507
- Pfizer$423
- AstraZeneca$333
- Axsome Therapeutics, Inc.$331
- Takeda Pharmaceuticals U.S.A., Inc.$318
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $856 |
| Lilly USA, LLC | 33 | $507 |
| Pfizer | 27 | $423 |
| AstraZeneca | 17 | $333 |
| Axsome Therapeutics, Inc. | 19 | $331 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $318 |
| Boehringer Ingelheim | 17 | $301 |
| Novo Nordisk | 13 | $230 |
| Lundbeck LLC | 12 | $211 |
| GSK | 8 | $207 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $183 |
| Sumitomo Pharma America, Inc. | 9 | $175 |
| Xeris Pharmaceuticals, Inc. | 9 | $143 |
| Sanofi-aventis U.S. LLC | 6 | $111 |
| Exact Sciences | 7 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $98 |
| Abbott | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $68 |
| Inspire Medical Systems, Inc. | 2 | $62 |
| Amgen | 4 | $58 |
| Bayer | 3 | $57 |
| Dexcom, Inc. | 3 | $56 |
| Amneal Pharmaceuticals LLC | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$121
How this compares
$5,186 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 132 | $159,733 |
| JardianceEmpagliflozin | 104 | $139,242 |
| MounjaroTirzepatide | 62 | $86,400 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 90 | $83,658 |
| OzempicSemaglutide | 64 | $77,730 |
| XareltoRivaroxaban | 58 | $61,027 |
| TrulicityDulaglutide | 22 | $45,068 |
| RybelsusSemaglutide | 18 | $41,947 |
| GemtesaVibegron | 22 | $30,402 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $29,228 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $28,700 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $27,552 |
| JanuviaSitagliptin Phosphate | 28 | $24,004 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $23,064 |
| TradjentaLinagliptin | 20 | $21,138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Spiriva Respimat | $301 | $194,365161 claims |
| PfizerEliquis | $423 | $159,733132 claims |
| Lilly USA, LLCMounjaro, Trulicity | $507 | $131,46984 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $207 | $131,275149 claims |
| Novo NordiskOzempic, Rybelsus | $230 | $119,67782 claims |
| Johnson & JohnsonXarelto | $34 | $61,02758 claims |
| AbbVieLinzess, Vraylar | $856 | $39,34327 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $175 | $30,40222 claims |
| AstraZenecaFarxiga | $333 | $7,95313 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $36 | $4,769654 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Columbia City
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.